Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Biogen Inc.

    NASDAQ: BIIB · Real-Time Price · USD
    131.07
    0.42 (0.32%)
    At close: Jun 16, 2025, 3:59 PM
    130.00
    -0.82%
    After-hours: Jun 16, 2025, 07:43 PM EDT

    Biogen Statistics

    Share Statistics

    Biogen has 146.53M shares outstanding. The number of shares has increased by 0.53% in one year.

    Shares Outstanding

    n/a
    		 146.53M

    Shares Change (YoY)

    n/a
    		 0.53%

    Shares Change (QoQ)

    n/a
    		 0.45%

    Owned by Institutions (%)

    n/a
    		 90.2%

    Shares Floating

    n/a
    		 146.28M

    Failed to Deliver (FTD) Shares

    n/a
    		 200

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 3.8M, so 2.59% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.8M

    Short % of Shares Out

    n/a
    		 2.59%

    Short % of Float

    n/a
    		 3.35%

    Short Ratio (days to cover)

    n/a
    		 2.13

    Valuation Ratios

    The PE ratio is 13.65 and the forward PE ratio is 8.47. Biogen's PEG ratio is 0.34.

    PE Ratio

    n/a
    		 13.65

    Forward PE

    n/a
    		 8.47

    PS Ratio

    n/a
    		 2.3

    Forward PS

    n/a
    		 2

    PB Ratio

    n/a
    		 1.33

    P/FCF Ratio

    n/a
    		 8.86

    PEG Ratio

    n/a
    		 0.34
    Financial Ratio History

    Enterprise Valuation

    Biogen has an Enterprise Value (EV) of 26.54B.

    EV / Sales

    n/a
    		 2.74

    EV / EBITDA

    n/a
    		 9.38

    EV / EBIT

    n/a
    		 9.23

    EV / FCF

    n/a
    		 10.55

    Financial Position

    The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.4.

    Current Ratio

    n/a
    		 1.35

    Quick Ratio

    n/a
    		 0.9

    Debt / Equity

    n/a
    		 0.4

    Debt / EBITDA

    n/a
    		 2.34

    Debt / FCF

    n/a
    		 2.64

    Interest Coverage

    n/a
    		 8.86

    Financial Efficiency

    Return on Equity is 9.76% and Return on Invested Capital is 7.83%.

    Return on Equity

    n/a
    		 9.76%

    Return on Assets

    n/a
    		 5.82%

    Return on Invested Capital

    n/a
    		 7.83%

    Revenue Per Employee

    n/a
    		 $1,272,307.69

    Profits Per Employee

    n/a
    		 $214,621.96

    Employee Count

    n/a
    		 7,605

    Asset Turnover

    n/a
    		 0.34

    Inventory Turnover

    n/a
    		 0.94

    Taxes

    Income Tax

    n/a
    		 273.8M

    Effective Tax Rate

    n/a
    		 14.37%

    Stock Price Statistics

    The stock price has increased by -42.12% in the last 52 weeks. The beta is 0.15, so Biogen's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.15

    52-Week Price Change

    n/a
    		 -42.12%

    50-Day Moving Average

    n/a
    		 123.88

    200-Day Moving Average

    n/a
    		 152.68

    Relative Strength Index (RSI)

    n/a
    		 53.85

    Average Volume (20 Days)

    n/a
    		 1,682,755

    Income Statement

    In the last 12 months, Biogen had revenue of 9.68B and earned 1.63B in profits. Earnings per share was 11.2.

    Revenue

    n/a
    		 9.68B

    Gross Profit

    n/a
    		 7.37B

    Operating Income

    n/a
    		 2.22B

    Net Income

    n/a
    		 1.63B

    EBITDA

    n/a
    		 2.83B

    EBIT

    n/a
    		 2.16B

    Earnings Per Share (EPS)

    n/a
    		 11.2
    Full Income Statement

    Balance Sheet

    The company has 2.38B in cash and 6.63B in debt, giving a net cash position of -4.26B.

    Cash & Cash Equivalents

    n/a
    		 2.38B

    Total Debt

    n/a
    		 6.63B

    Net Cash

    n/a
    		 -4.26B

    Retained Earnings

    n/a
    		 19.26B

    Total Assets

    n/a
    		 28.03B

    Working Capital

    n/a
    		 2.33B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 2.88B and capital expenditures -359.8M, giving a free cash flow of 2.52B.

    Operating Cash Flow

    n/a
    		 2.88B

    Capital Expenditures

    n/a
    		 -359.8M

    Free Cash Flow

    n/a
    		 2.52B

    FCF Per Share

    n/a
    		 17.27
    Full Cash Flow Statement

    Margins

    Gross margin is 76.12%, with operating and profit margins of 22.93% and 16.87%.

    Gross Margin

    n/a
    		 76.12%

    Operating Margin

    n/a
    		 22.93%

    Pretax Margin

    n/a
    		 19.7%

    Profit Margin

    n/a
    		 16.87%

    EBITDA Margin

    n/a
    		 29.24%

    EBIT Margin

    n/a
    		 22.93%

    FCF Margin

    n/a
    		 26%

    Dividends & Yields

    BIIB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.33%

    FCF Yield

    n/a
    		 11.29%
    Dividend Details

    Analyst Forecast

    The average price target for BIIB is $183.5, which is 40% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $183.5

    Price Target Difference

    n/a
    		 40%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 26
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $56

    Lynch Upside

    n/a
    		 -57.27%

    Graham Number

    n/a
    		 170.05

    Graham Upside

    n/a
    		 29.74%

    Stock Splits

    The last stock split was on Jan 18, 2001. It was a forward split with a ratio of 3:1.

    Last Split Date

    n/a
    		 Jan 18, 2001

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:1

    Scores

    Altman Z-Score

    n/a
    		 2.67

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist